The End Is the Beginning: Parkinson’s Disease in the Light of Brain Imaging
Open Access
- 10 October 2017
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 9, 330
- https://doi.org/10.3389/fnagi.2017.00330
Abstract
Parkinson’s disease (PD), the most common neurodegenerative disorder is characterized by abnormal accumulation of α-synuclein aggregates known as Lewy bodies (LB) and loss of nigrostriatal dopaminergic neurons. Recent neuroimaging studies suggest that in the early phases of PD, synaptic and axonal damage anticipate the onset of a frank neuronal death. Paralleling, even post mortem studies on the brain of affected patients and on animal models support that synapses might represent the primary sites of functional and pathological changes. Indeed, α-synuclein microaggregation and spreading at terminals, by dysregulating the synaptic junction, would block neurotransmitter release, thus triggering a retrograde neurodegenerative process ending with neuronal cell loss by proceeding through the axons. Rather than neurodegeneration, loss of dopaminergic neuronal endings and axons could thus underlie the onset of connectome dysfunction and symptoms in PD and parkinsonisms. However, the manifold biases deriving from the interpretation of human brain imaging data hinder the validation of this hypothesis. Here, we present pivotal evidence supporting that novel comparative brain imaging studies, in patients and experimental models of PD in preliminary stages of disease, could be instrumental for proving whether synaptic endings are the sites where degeneration begins and initiating the factual achievement of disease modifying approaches. The need for such investigations is timely to define an early therapeutic window of intervention to attempt disease halting by terminal and/or axonal healing.Funding Information
- Fondazione Cariplo (2014-0769)
- Michael J. Fox Foundation for Parkinson’s Research (#10742)
This publication has 37 references indexed in Scilit:
- Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's diseaseNeuroImage: Clinical, 2017
- The Threshold Theory for Parkinson's DiseaseTrends in Neurosciences, 2016
- Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECTMovement Disorders, 2016
- Synaptic failure and α‐synucleinMovement Disorders, 2016
- The Synaptic Function of α-SynucleinJournal of Parkinson's Disease, 2015
- Nigral anatomy and striatal denervation in genetic Parkinsonism: A family reportMovement Disorders, 2015
- The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical studyNeurobiology of Disease, 2012
- Parkinson’s disease: The non-motor issuesParkinsonism & Related Disorders, 2011
- Redistribution of DAT/α-Synuclein Complexes Visualized by “In Situ” Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's DiseasePLOS ONE, 2011
- VMAT2 and dopamine neuron loss in a primate model of Parkinson’s diseaseJournal of Neurochemistry, 2007